We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
76
Intuitive Surgical
ISRG
$130B
$27.6M 0.46%
59,942
+551
+0.9% +$279K
MSCI icon
77
MSCI
MSCI
$41.4B
$27.5M 0.45%
51,068
+14,788
+41% +$8.34M
BKR icon
78
Baker Hughes
BKR
$61.7B
$26.7M 0.44%
438,017
+88,043
+25% +$5.09M
MBX
79
MBX Biosciences
MBX
$3.2B
$26.6M 0.44%
890,000
– –
CNTA
80
DELISTED
Centessa Pharmaceuticals
CNTA
$26.5M 0.44%
+668,142
New +$17.1M
SION
81
Sionna Therapeutics
SION
$274M
$25.9M 0.43%
645,530
+6,485
+1% +$247K
FTDR icon
82
Frontdoor
FTDR
$5.71B
$25.7M 0.43%
486,232
+1,071
+0.2% +$63.9K
EQT icon
83
EQT Corp
EQT
$34.3B
$25.5M 0.42%
399,975
-9,632
-2% -$564K
SITM icon
84
SiTime
SITM
$18B
$25.4M 0.42%
73,665
-82,318
-53% -$30.3M
RVMD icon
85
Revolution Medicines
RVMD
$47.4B
$25.4M 0.42%
261,425
-116,836
-31% -$11.8M
IRON icon
86
Disc Medicine
IRON
$3.17B
$25.3M 0.42%
395,572
+180
+0% +$12.5K
CGON icon
87
CG Oncology
CGON
$7B
$25M 0.41%
369,985
+57,540
+18% +$3.26M
WEC icon
88
WEC Energy
WEC
$34.6B
$24.2M 0.4%
209,072
+2,355
+1% +$265K
VRT icon
89
Vertiv
VRT
$104B
$23.8M 0.39%
95,010
-10,989
-10% -$2.44M
IMMX icon
90
Immix Biopharma
IMMX
$1.02B
$23.2M 0.38%
2,549,019
– –
ARWR icon
91
Arrowhead Research
ARWR
$12.5B
$23.2M 0.38%
370,000
– –
IP icon
92
International Paper
IP
$21.1B
$23M 0.38%
645,438
-80,782
-11% -$3.36M
ULS icon
93
UL Solutions
ULS
$15.3B
$22.8M 0.38%
+267,774
New +$21.1M
MSI icon
94
Motorola Solutions
MSI
$80.5B
$22.8M 0.38%
52,581
-21,448
-29% -$9.29M
SHW icon
95
Sherwin-Williams
SHW
$83.8B
$22.8M 0.38%
71,124
+520
+0.7% +$179K
PNR icon
96
Pentair
PNR
$9.91B
$22.5M 0.37%
259,595
-66,685
-20% -$6.53M
HAL icon
97
Halliburton
HAL
$29.6B
$22.2M 0.37%
568,546
+503,202
+770% +$17.4M
CEG icon
98
Constellation Energy
CEG
$100B
$22.1M 0.37%
78,108
+4,072
+6% +$1.24M
OVID icon
99
Ovid Therapeutics
OVID
$572M
$22M 0.36%
9,916,911
+5,631,911
+131% +$10.1M
ADCT icon
100
ADC Therapeutics
ADCT
$143M
$21.4M 0.35%
5,701,655
+2,337,588
+69% +$9.22M
2 3
4
5 6

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.